DMN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Diamyd Medical AB

Watchlist Manager

Watchlist

Price: 0.07 EUR 1.16%

Market Cap: €6.8m

D	Diamyd Medical AB F:DMN	SE
	Medicus Pharma Ltd NASDAQ:MDCX	CA

Profitability Summary

Diamyd Medical AB's profitability score is 2/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Negative 3Y Average Gross Margin

-5 064%

Negative Operating Margin

-66 877%

Negative 3Y Average Operating Margin

-82 170%

Declining Operating Margin

-21 217% > -66 877%

Negative Net Margin

-65 964%

Negative 3Y Average Net Margin

-78 928%

Declining Net Margin

-21 259% > -65 964%

Negative Free Cash Flow Margin

-45 080%

Negative 3Y Average Free Cash Flow Margin

-76 057%

Declining Free Cash Flow Margin

-22 418% > -45 080%

Negative ROE

-97%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-253%

Declining ROIC

-165% > -467%

View All

Hide

Collapse

2 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.